17 participants
Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2025-11-17
- Start Date:
- 2024-09-01
- Completion:
- 2025-11-20
Conditions
- HCC - Hepatocellular Carcinoma
- SBRT
- TACE
- Immunotherapy
- Targeted Therapy
No Results Yet